Mozambique vs Qatar: Statin use vs. average non-HDL cholesterol levels
Mozambique
3
in 2018
Qatar
3
in 2018
Mozambique rank
146th
Qatar rank
146th
Statin use vs. average non-HDL cholesterol levels over time
- Mozambique
- Qatar
How they compare
Mozambique currently reports 3 against 3 in Qatar, a difference of 0.
Across all 39 years both countries report, Qatar has been ahead every year.
Mozambique ranks 146th and Qatar ranks 146th of 191 countries.
Qatar has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Mozambique | Qatar | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 2.47 | 3.85 | 1.38 | Qatar |
| 1990s | 2.66 | 3.95 | 1.29 | Qatar |
| 2000s | 2.76 | 3.74 | 0.98 | Qatar |
| 2010s | 2.91 | 3.26 | 0.3444 | Qatar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher statin use vs. average non-hdl cholesterol levels, Mozambique or Qatar?
- Mozambique, at 3 against 3 in Qatar as of 2018.
- What is the difference in statin use vs. average non-hdl cholesterol levels between Mozambique and Qatar?
- 0, with Mozambique ahead.
- How many years of comparable data are there for Mozambique and Qatar?
- 39 years are reported by both, from 1980 to 2018.
- How do Mozambique and Qatar rank globally for statin use vs. average non-hdl cholesterol levels?
- Mozambique ranks 146th and Qatar ranks 146th of 191 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Statin use vs. average non-HDL cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The use of statins in the population. This is compared to average non-HDL cholesterol levels, in mmol/L. Statins are a type of drug that reduce non-HDL cholesterol levels, and are used to treat and prevent cardiovascular diseases in people at heightened risk. Their usage is measured in Defined Daily Doses, per 1,000 people.